Tags

Type your tag names separated by a space and hit enter

An Exclusive Interview With CRISPR.
AMA J Ethics. 2019 12 01; 21(12):E1079-1088.AJ

Abstract

This article chronicles a didactic encounter between an ethics-minded physician-scientist and a personified genome editing technology called clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins, commonly abbreviated as CRISPR/Cas, or simply CRISPR. The interview considers clinically and ethically relevant questions about this technology related to patient safety, therapeutic efficacy, equitable access, and global governance of humanity's genetic legacy.

Authors+Show Affiliations

A senior policy analyst at the American Medical Association in Chicago, Illinois.

Pub Type(s)

Interview

Language

eng

PubMed ID

31876473

Citation

McConnell, Sean C.. "An Exclusive Interview With CRISPR." AMA Journal of Ethics, vol. 21, no. 12, 2019, pp. E1079-1088.
McConnell SC. An Exclusive Interview With CRISPR. AMA J Ethics. 2019;21(12):E1079-1088.
McConnell, S. C. (2019). An Exclusive Interview With CRISPR. AMA Journal of Ethics, 21(12), E1079-1088. https://doi.org/10.1001/amajethics.2019.1079
McConnell SC. An Exclusive Interview With CRISPR. AMA J Ethics. 2019 12 1;21(12):E1079-1088. PubMed PMID: 31876473.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - An Exclusive Interview With CRISPR. A1 - McConnell,Sean C, Y1 - 2019/12/01/ PY - 2019/12/27/entrez PY - 2019/12/27/pubmed PY - 2019/12/27/medline SP - E1079 EP - 1088 JF - AMA journal of ethics JO - AMA J Ethics VL - 21 IS - 12 N2 - This article chronicles a didactic encounter between an ethics-minded physician-scientist and a personified genome editing technology called clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins, commonly abbreviated as CRISPR/Cas, or simply CRISPR. The interview considers clinically and ethically relevant questions about this technology related to patient safety, therapeutic efficacy, equitable access, and global governance of humanity's genetic legacy. SN - 2376-6980 UR - https://www.unboundmedicine.com/medline/citation/31876473/An_Exclusive_Interview_With_CRISPR_ L2 - https://journalofethics.ama-assn.org/article/exclusive-interview-crispr/2019-12 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.